跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OPZELURA 15 MG/G CREMA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
OPZELURA 15 MG/G CREMA
Approved
STANDARD
OPZELURA 15 MG/G CREMA
Incyte Biosciences Distribution B.V.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 13, 2023
Approval ID
25081f7c9285746b
Company
Incyte Biosciences Distribution B.V.
Type
Standard
Approval Details
Approval Id
25081f7c9285746b
Drug Cima Aemps Name
OPZELURA 15 MG/G CREMA
Register Number
1231726001
Holder Company Name
Incyte Biosciences Distribution B.V.
Marketing Company Name
Incyte Biosciences Iberia S.L.
Holder Company Detail Path
/organization/incyte-biosciences-distribution-b-v
Authorization Date
2023-07-13
Dosage Form
CREMA
Dose
15 mg/g
Route Of Administration
USO CUTÁNEO
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Incyte Biosciences Distribution B.V.
Company Detail Path
/organization/incyte-biosciences-distribution-b-v
Company Information
Pharmaceutical Company Name
Incyte Biosciences Distribution B.V.
Country Name
Sweden
Address
Utländsk Adr - Foreign Addr
Active Ingredients
RUXOLITINIB FOSFATO
1,98 g
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 13, 2023
Approval ID
25081f7c9285746b
Type
Standard
Back to CIMA-AEMPS Approvals